10 Pharmaceuticals Stocks to Buy Now

The grades of 10 Pharmaceuticals stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”) or “B” overall (“buy”).

ANI Pharmaceuticals, Inc. (ANIP) gets a higher grade this week, advancing from a D last week to a B. ANI Pharmaceuticals, Inc. develops, manufactures, and markets prescription and over-the-counter pharmaceuticals. The company also gets A’s in earnings revisions and earnings surprise. For more information, get Portfolio Grader’s complete analysis of ANIP stock.

Merck & Co., Inc. (MRK) improves from a C to a B rating this week. Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company also gets A’s in earnings growth and earnings momentum. For more information, get Portfolio Grader’s complete analysis of MRK stock.

The rating of Zoetis, Inc. Class A (ZTS) moves up this week, rising from a C to a B. The company also gets A’s in operating margin growth, earnings momentum, and return on equity. For more information, get Portfolio Grader’s complete analysis of ZTS stock.

This week, Heska Corporation’s (HSKA) ratings are up from a B last week to a A. Heska Corporation discovers, develops, manufactures, and markets companion animal health products, primarily for dogs, cats, and horses. The company also gets A’s in operating margin growth, earnings growth, earnings revisions, and earnings surprise. For more information, get Portfolio Grader’s complete analysis of HSKA stock.

Relypsa, Inc.’s (RLYP) ratings are looking better this week, moving up to a B from last week’s C. For more information, get Portfolio Grader’s complete analysis of RLYP stock.

Aerie Pharmaceuticals, Inc. (AERI) shows solid improvement this week. The company’s rating rises from a C to a B. For more information, get Portfolio Grader’s complete analysis of AERI stock.

Amphastar Pharmaceuticals, Inc. (AMPH) boosts its rating from a C to a B this week. The company also gets A’s in earnings revisions. For more information, get Portfolio Grader’s complete analysis of AMPH stock.

Cynapsus Therapeutics Inc. (CYNA) earns a B this week, jumping up from last week’s grade of C. The company also gets A’s in earnings revisions and earnings momentum. For more information, get Portfolio Grader’s complete analysis of CYNA stock.

Omeros Corporation (OMER) is seeing ratings go up from a C last week to a B this week. Omeros Corporation is a biopharmaceutical company developing a pipeline of product candidates for use in orthopedics, rheumatology, urology, cardiovascular medicine, general surgery and pain management. The company also gets A’s in sales growth, earnings revisions, and earnings surprise. For more information, get Portfolio Grader’s complete analysis of OMER stock.

This is a strong week for ProPhase Labs, Inc. (PRPH). The company’s rating climbs to B from the previous week’s C. ProPhase Labs, Inc. manufactures zinc gluconate glycine lozenges and homeopathic gum. For more information, get Portfolio Grader’s complete analysis of PRPH stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, https://investorplace.com/2016/08/10-pharmaceuticals-stocks-to-buy-now/.

©2022 InvestorPlace Media, LLC